Jerry A. Shields
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jerry A. Shields has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Carol L. Shields
Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, United States
7 shared publicationsCarol L Shields
4 shared publicationsRalph C Eagle
4 shared publicationsRalph C. Eagle
3 shared publications- Arman Mashayekhi
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
1 shared publication Arupa Ganguly
1 shared publication
Latest Publications
- Open Access
- 1 February 2010
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (2) , 241-243
Harvesting Fresh Tumor Tissue From Enucleated Eyes
There is an increasing need to obtain fresh tumor tissue and normal tissue for genetic studies and research following enucleation of an eye for uveal melanoma, retinoblastoma, and other lesions. A concern about doing this is that the globe will often collapse and lead to difficulties with gross and histopathologic interpretation. The technique reported herein is based on the creation of an opening in the sclera using an 8-mm corneal trephine followed by removal of tumor tissue. This method provides adequate tissue, preserves the spherical configuration of the eye, and allows for excellent histopathologic sections.
- 1 February 2010
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (2) , 241-243
Open AccessHarvesting Fresh Tumor Tissue From Enucleated Eyes
There is an increasing need to obtain fresh tumor tissue and normal tissue for genetic studies and research following enucleation of an eye for uveal melanoma, retinoblastoma, and other lesions. A concern about doing this is that the globe will often collapse and lead to difficulties with gross and histopathologic interpretation. The technique reported herein is based on the creation of an opening in the sclera using an 8-mm corneal trephine followed by removal of tumor tissue. This method provides adequate tissue, preserves the spherical configuration of the eye, and allows for excellent histopathologic sections.
- 1 December 2009
- Published by Wolters Kluwer Health in Cornea
- Vol. 28 (10) , 1191-1193
Iris Melanoma Arising From Sector Congenital Ocular Melanocytosis in a Child
To report a clinicopathologic correlation of a melanoma arising from iris component of ocular melanocytosis in a child. A 13-year-old boy developed a progressive iris nodule arising from sector iris pigmentation that was a component of congenital ocular melanocytosis involving the iris, ciliary body and choroid. The tumor was examined clinically and with ultrasound biomicroscopy (UBM), removed by peripheral iridocyclectomy, and studied histopathologically. Clinically, the pigmented nodule was 3 mm in diameter, located within the sector iris pigmentation, and was 2.4 mm in thickness as measured by UBM. Histopathologically, it was composed predominately of spindle B melanoma cells with adjacent spindle and dendritic melanocytes compatible with iris melanocytosis. Although highly unusual, melanoma can arise in the sector iris pigmentation that is often a component of congenital ocular melanocytosis. Even young patients with ocular melanocytosis should be examined periodically for development of melanoma in the ciliary body and choroid.
- 1 December 2009
- Published by Wolters Kluwer Health in Cornea
- Vol. 28 (10) , 1191-1193
Iris Melanoma Arising From Sector Congenital Ocular Melanocytosis in a Child
To report a clinicopathologic correlation of a melanoma arising from iris component of ocular melanocytosis in a child. A 13-year-old boy developed a progressive iris nodule arising from sector iris pigmentation that was a component of congenital ocular melanocytosis involving the iris, ciliary body and choroid. The tumor was examined clinically and with ultrasound biomicroscopy (UBM), removed by peripheral iridocyclectomy, and studied histopathologically. Clinically, the pigmented nodule was 3 mm in diameter, located within the sector iris pigmentation, and was 2.4 mm in thickness as measured by UBM. Histopathologically, it was composed predominately of spindle B melanoma cells with adjacent spindle and dendritic melanocytes compatible with iris melanocytosis. Although highly unusual, melanoma can arise in the sector iris pigmentation that is often a component of congenital ocular melanocytosis. Even young patients with ocular melanocytosis should be examined periodically for development of melanoma in the ciliary body and choroid.
- Open Access
- 1 October 2009
- Published by Medknow in Saudi Journal of Ophthalmology
- Vol. 23 (3-4) , 197-201
Glial tumors of the retina. The 2009 King Khaled Memorial Lecture
Retinal glial tumors and pseudotumors can be classified into astrocytic hamartoma, acquired retinal astrocytoma, massive gliosis, and focal nodular gliosis. Each has different clinical manifestations. Astrocytic hamartoma is usually seen patients who have some manifestations of tuberous sclerosis complex (TSC). It can occur as a noncalcified or calcified variety, and often a combination of the two, and has fairly typical features with fluorescein angiography, ultrasonography, and optical coherence tomography. Although it is generally a stationary lesion, an aggressive variant seen in very young children with TSC can lead to exudative retinopathy, retinal detachment, and neovascular glaucoma. Acquired astrocytoma general occurs in somewhat older individuals who do not have TSC. Like the aggressive form of astrocytic hamartoma it can lead to exudative retinopathy and exudative retinal detachment. Pseudoneoplastic diffuse retinal gliosis can occur as massive glial proliferation in eyes with prior trauma, Coats disease, retinal angiomatosis and other conditions and often occurs in blind eyes. Pseudoneoplastic focal retinal gliosis is characterized by a very superficial, white, noncalcified lesion in otherwise normal eye in somewhat older individuals. Recognition of these glial lesions is important because they can resemble malignant tumors and have different clinical courses and complications.
- 1 October 2009
- Published by Medknow in Saudi Journal of Ophthalmology
- Vol. 23 (3-4) , 197-201
Open AccessGlial tumors of the retina. The 2009 King Khaled Memorial Lecture
Retinal glial tumors and pseudotumors can be classified into astrocytic hamartoma, acquired retinal astrocytoma, massive gliosis, and focal nodular gliosis. Each has different clinical manifestations. Astrocytic hamartoma is usually seen patients who have some manifestations of tuberous sclerosis complex (TSC). It can occur as a noncalcified or calcified variety, and often a combination of the two, and has fairly typical features with fluorescein angiography, ultrasonography, and optical coherence tomography. Although it is generally a stationary lesion, an aggressive variant seen in very young children with TSC can lead to exudative retinopathy, retinal detachment, and neovascular glaucoma. Acquired astrocytoma general occurs in somewhat older individuals who do not have TSC. Like the aggressive form of astrocytic hamartoma it can lead to exudative retinopathy and exudative retinal detachment. Pseudoneoplastic diffuse retinal gliosis can occur as massive glial proliferation in eyes with prior trauma, Coats disease, retinal angiomatosis and other conditions and often occurs in blind eyes. Pseudoneoplastic focal retinal gliosis is characterized by a very superficial, white, noncalcified lesion in otherwise normal eye in somewhat older individuals. Recognition of these glial lesions is important because they can resemble malignant tumors and have different clinical courses and complications.
- 14 September 2009
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 127 (9) , 1222-1224
Retrograde Metastasis of Cutaneous Melanoma to Conjunctival Lymphatics
Letter from JAMA Ophthalmology — Retrograde Metastasis of Cutaneous Melanoma to Conjunctival Lymphatics
- 14 September 2009
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 127 (9) , 1222-1224
Retrograde Metastasis of Cutaneous Melanoma to Conjunctival Lymphatics
Letter from JAMA Ophthalmology — Retrograde Metastasis of Cutaneous Melanoma to Conjunctival Lymphatics
- 14 September 2009
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 127 (9) , 1224
Age-Related Hyperplasia of the Nonpigmented Ciliary Body Epithelium (Fuchs Adenoma) Simulating a Ciliary Body Malignant Neoplasm
Letter from JAMA Ophthalmology — Age-Related Hyperplasia of the Nonpigmented Ciliary Body Epithelium (Fuchs Adenoma) Simulating a Ciliary Body Malignant Neoplasm
- 14 September 2009
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 127 (9) , 1224
Age-Related Hyperplasia of the Nonpigmented Ciliary Body Epithelium (Fuchs Adenoma) Simulating a Ciliary Body Malignant Neoplasm
Letter from JAMA Ophthalmology — Age-Related Hyperplasia of the Nonpigmented Ciliary Body Epithelium (Fuchs Adenoma) Simulating a Ciliary Body Malignant Neoplasm
- 10 November 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (11) , 1602-1603
Cavernous Hemangioma of the Iris
Letter from JAMA Ophthalmology — Cavernous Hemangioma of the Iris
- 10 November 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (11) , 1602-1603
Cavernous Hemangioma of the Iris
Letter from JAMA Ophthalmology — Cavernous Hemangioma of the Iris
- 1 March 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (3) , 416-419
Role of Cytogenetics in Management of Uveal Melanoma
Opinion from JAMA Ophthalmology — Role of Cytogenetics in Management of Uveal Melanoma
- 1 March 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (3) , 416-419
Role of Cytogenetics in Management of Uveal Melanoma
Opinion from JAMA Ophthalmology — Role of Cytogenetics in Management of Uveal Melanoma
- 1 September 2006
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 124 (9) , 1344-1346
Treating Some Small Melanocytic Choroidal Lesions Without Waiting for Growth
It is generally acknowledged that the best management for most cancers is early detection and definitive treatment. Several malignancies, including breast cance
- 1 September 2006
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 124 (9) , 1344-1346
Treating Some Small Melanocytic Choroidal Lesions Without Waiting for Growth
It is generally acknowledged that the best management for most cancers is early detection and definitive treatment. Several malignancies, including breast cance
- 28 February 2006
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 244 (9) , 1071-1072
Photodynamic therapy for choroidal hemangioma
- 28 February 2006
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 244 (9) , 1071-1072
Photodynamic therapy for choroidal hemangioma